লোডিং...
Predicting poor peripheral blood stem cell collection in patients with multiple myeloma receiving pre-transplant induction therapy with novel agents and mobilized with cyclophosphamide plus granulocyte-colony stimulating factor: results from a Gruppo Italiano Malattie EMatologiche dell’Adulto Multiple Myeloma Working Party study
INTRODUCTION: A still not well defined proportion of patients with multiple myeloma (MM) and eligible for autologous stem cell transplantation (AuSCT) fails to mobilize CD34+ peripheral blood stem cells (PBSC) at all or to collect an adequate number for a safe procedure or sufficient for multiple tr...
সংরক্ষণ করুন:
প্রকাশিত: | Stem Cell Res Ther |
---|---|
প্রধান লেখক: | , , , , , , , , , , , , , , , , , , , , , |
বিন্যাস: | Artigo |
ভাষা: | Inglês |
প্রকাশিত: |
BioMed Central
2015
|
বিষয়গুলি: | |
অনলাইন ব্যবহার করুন: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4425876/ https://ncbi.nlm.nih.gov/pubmed/25889496 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13287-015-0033-1 |
ট্যাগগুলো: |
ট্যাগ যুক্ত করুন
কোনো ট্যাগ নেই, প্রথমজন হিসাবে ট্যাগ করুন!
|